Hadija Trojer
Impact in
-
- IL-33, ST2, and ILC Pathways
- interferon and immune responses
- Immunodeficiency and Autoimmune Disorders
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammasome and immune disorders 9
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
-
- interferon and immune responses 3
- IL-33, ST2, and ILC Pathways 2
- Immune Cell Function and Interaction 2
- Co-authors
- Helen J. Lachmann (14 shared papers)Philip N. Hawkins (14 shared papers)Dorota Rowczenio (10 shared papers)Thirusha Lane (10 shared papers)Anna Baginska (6 shared papers)Paul Brogan (6 shared papers)Ebun Omoyinmi (5 shared papers)Anna Mensa‐Vilaró (3 shared papers)
- Journals
- Pediatric Rheumatology (4 papers)Lara D. Veeken (3 papers)Human Mutation (1 paper)Blood (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United KingdomSpainPoland
In The Last Decade
Hadija Trojer
11 papers receiving 338 citations
Peers
Comparison fields: 5 of 45
- Immunology 168
- Nephrology 52
- Hematology 78
- Rheumatology 80
- Molecular Biology 282
Countries citing papers authored by Hadija Trojer
This map shows the geographic impact of Hadija Trojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadija Trojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadija Trojer more than expected).
Fields of papers citing papers by Hadija Trojer
This network shows the impact of papers produced by Hadija Trojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadija Trojer. The network helps show where Hadija Trojer may publish in the future.
Co-authors
The 25 scholars most cited alongside Hadija Trojer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 95 | |
| 2 | 2017 | 68 | |
| 3 | 2016 | 43 | |
| 4 | 2013 | 43 | |
| 5 | 2016 | 43 | |
| 6 | 2018 | 29 | |
| 7 | 2019 | 14 | |
| 8 | 2015 | 5 | |
| 9 | 2015 | 4 | |
| 10 | Natural history of hereditary lysozyme amyloidosis | 2010 | 1 |
| 11 | 2015 | 1 | |
| 12 | 2016 | 0 | |
| 13 | 2013 | 0 | |
| 14 | 2019 | 0 |
About Hadija Trojer
Hadija Trojer is a scholar working on Molecular Biology, Immunology, Nephrology, Rheumatology and Pathology and Forensic Medicine, having authored 14 papers that have together received 346 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (9 papers), interferon and immune responses (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), IL-33, ST2, and ILC Pathways (2 papers), Immune Cell Function and Interaction (2 papers), Renal Diseases and Glomerulopathies (1 paper), Metabolism and Genetic Disorders (1 paper) and Dermatological and Skeletal Disorders (1 paper). The work is most often cited by research in Immunology (168 citations), Nephrology (52 citations), Hematology (78 citations), Rheumatology (80 citations) and Molecular Biology (282 citations). Hadija Trojer has collaborated with scholars based in United Kingdom, Spain and Poland. Frequent co-authors include Helen J. Lachmann, Philip N. Hawkins, Dorota Rowczenio, Thirusha Lane, Anna Baginska, Paul Brogan, Ebun Omoyinmi, Anna Mensa‐Vilaró, Juan I. Aróstegui and Julian D. Gillmore. Their work appears in journals such as Pediatric Rheumatology, Lara D. Veeken, Human Mutation, Blood and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.